Evidence map›Paper›PMID 32418818›Full record

ArticleThe Journal of pediatrics2020

Probiotic Use and Safety in the Neonatal Intensive Care Unit: A Matched Cohort Study.

Keyaria D Gray, Julia A Messina, Christopher Cortina, Tanasha Owens, Madeline Fowler, Matthew Foster, Simi Gbadegesin, Reese H Clark, Daniel K Benjamin, Kanecia O Zimmerman and 1 more

Registry-linked trialOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in The Journal of pediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04977817 (A Prospective/Retrospective Chart Review of the Effects of a Probiotic Dietary Supplement on Days of Total Parenteral Nutrition in Two Neonatal Intensive Care Units), which is not on this map. Cited by 26 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 4 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04977817 completednot on this mapstarted 2021, after this paper: background citation

A Prospective/Retrospective Chart Review of the Effects of a Probiotic Dietary Supplement on Days of Total Parenteral Nutrition in Two Neonatal Intensive Care Units

TypeobservationalSponsorPediatrixRan2021 to 2022Enrolled150ConditionsTotal Parenteral Nutrition, Necrotizing Enterocolitis of NewbornArmsSimilac Probiotic Tri-Blend
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 4 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Probiotics and necrotizing enterocolitis in preterm infants after the food and drug administration warning actions.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  7. Review
  8. Review
  9. Review
  10. Probiotics and the Risk of Infection.Clinics in perinatology · 2025
    Review
  11. Review
  12. Review
  13. Influence of infant microbiome on health and development.Clinical and experimental pediatrics · 2024
    Article
  14. Review
  15. Effects of prophylactic probiotics supplementation on infants born very preterm or very low birth weight.Journal of perinatology : official journal of the California Perinatal Association · 2023
    Article
  16. Review
  17. Early-life microbiota-immune homeostasis.Frontiers in immunology · 2023
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Keyaria D GrayDepartment of Pediatrics, Duke University School of Medicine, Durham, NC.
Julia A MessinaDuke Clinical Research Institute, Durham, NC; and.
Christopher CortinaDuke Clinical Research Institute, Durham, NC; and.
Tanasha OwensDuke Clinical Research Institute, Durham, NC; and.
Madeline FowlerDuke Clinical Research Institute, Durham, NC; and.
Matthew FosterDuke Clinical Research Institute, Durham, NC; and.
Simi GbadegesinDuke Clinical Research Institute, Durham, NC; and.
Reese H ClarkPediatrix Medical Group, Inc, Sunrise, FL.
Daniel K BenjaminDuke Clinical Research Institute, Durham, NC; and.
Kanecia O ZimmermanDuke Clinical Research Institute, Durham, NC; and.
Rachel G GreenbergDepartment of Pediatrics, Duke University School of Medicine, Durham, NC; Duke Clinical Research Institute, Durham, NC; and. Electronic address: rachel.greenberg@duke.edu.
Clinical Research Institute · USDuke University · USSunrise Medical (United States) · US

Funding

Transplant Infectious Diseases Interdisciplinary Research Training Grant (TIDIRTGT32AI100851 · NIAID · DUKE UNIVERSITY · PI ALEXANDER, BARBARA D · 2013 to 2022
$1.8M
NIH Summer Research Experience Programs (R25)R25HD076475 · NICHD · DUKE UNIVERSITY · PI BENJAMIN, DANIEL K. · 2013 to 2023
$1.1M
Investigating polypharmacy-related adverse events in critically ill children using electronic health records and simulated drug levelsK23HD091398 · NICHD · DUKE UNIVERSITY · PI ZIMMERMAN, KANECIA OBIE · 2017 to 2020
$629k
NIAAA NIH HHS HHSN275201000003CNIAID NIH HHS T32 AI100851NICHD NIH HHS HHSN275201000003INICHD NIH HHS K23 HD091398NICHD NIH HHS R25 HD076475
6 · The paper itself

Abstract

objectiveTo determine the prevalence of probiotic administration in infants born preterm over time, as well as the association between probiotic administration and select adverse outcomes. STUDY

designWe performed a multicenter cohort study of infants 23-29 weeks of gestational age admitted to 289 neonatal intensive care units from 1997 to 2016. We evaluated the type of probiotics given and prevalence of exposure to probiotics over time and by site. We matched infants exposed to probiotics by several factors to unexposed infants receiving enteral feeds on the same postnatal day. We performed conditional logistic regression to evaluate the association between probiotics exposure and adverse outcomes, including necrotizing enterocolitis (NEC), bloodstream infections, meningitis, and death.

resultsOf 78 076 infants, 3626 (4.6%) received probiotics. Probiotic use increased over the study period and varied among neonatal intensive care units. We matched 2178 infants exposed to probiotics to 33 807 without exposure. Probiotic administration was associated with a decrease in NEC (OR 0.62, 95% CI 0.48-0.80) and death (OR 0.52, 95% CI 0.39-0.70), an increase in Candida infection (OR 2.23, 95% CI 1.29-3.85), but no increase in bloodstream infection (OR 0.86, 95% CI 0.70-1.05) or meningitis (OR 1.18, 95% CI 0.40-3.46).

conclusionsProbiotic use increased over time and was associated with decreased odds of NEC and death. Prospective, randomized-controlled studies of specific probiotic products are needed to further investigate the safety and efficacy of probiotics in preterm infants.

Indexed as

Cohort StudiesFemaleHumansInfantInfant, PrematureInfant, Premature, DiseasesIntensive Care Units, NeonatalMaleProbioticsTreatment Outcomeinfants born pretermprobiotic safetyprobiotic use

Identifiers

PMID32418818
PMCPMC7321859
OpenAlexW3025076436

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.